DUBLIN--(BUSINESS WIRE)--Aug 30, 2018--The "Global Systemic Psoriasis Therapeutics Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

The Global Systemic Psoriasis Therapeutics Market to grow at a CAGR of 10.07% during the period 2018-2022.

This report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. To calculate the market size, the report considers the revenue generated from sale of different systemic psoriasis therapeutics.

One trend affecting this market is the rise in cost of systemic psoriasis therapy. The cost of the treatment depends on the severity of the disease. The first line of treatment is usually a systemic agent, and if ineffective a more potent systemic agent is used which increases the cost of treatment.

According to the report, one driver influencing this market is the need for affordable therapies. Topical treatments are most often purchased medication. Biologics are the most expensive medication and treatment failure can increase the medication cost.

Further, the report states that one challenge affecting this market is the patent expiry of drugs. The patent for major biologics for systemic psoriasis therapy have expired, which increases chances of adoption of biosimilars.

Key vendors

AbbVie Amgen Celgene Johnson & Johnson

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

PART 05: MARKET SIZING 2017-2022

PART 06: FIVE FORCES ANALYSIS

Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition

PART 07: PIPELINE ANALYSIS

Pipeline analysis Discontinued psoriasis therapies

PART 08: MARKET SEGMENTATION BY PRODUCT

Segmentation by product Comparison by product Small molecules Biologics Market opportunity by product

PART 09: MARKET SEGMENTATION BY ROA

Oral Parenteral

PART 10: MARKET SEGMENTATION BY SEVERITY OF DISEASE

PART 11: MARKET SEGMENTATION BY END-USER

Segmentation by end-user Hospitals Retail pharmacies

PART 12: CUSTOMER LANDSCAPE

PART 13: REGIONAL LANDSCAPE

Geographical segmentation Regional comparison Market opportunity

PART 14: DECISION FRAMEWORK

PART 15: DRIVERS AND CHALLENGES

PART 16: MARKET TRENDS

Rise in cost of systemic psoriasis therapy Introduction of biologics Gene therapy for psoriasis Use of combination therapy Research in precision healthcare infrastructure

PART 17: VENDOR LANDSCAPE

Overview Landscape disruption

PART 18: VENDOR ANALYSIS

Vendors covered Vendor classification Market positioning of vendors

For more information about this report visit https://www.researchandmarkets.com/research/d66xbp/global_systemic?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180830005674/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Psoriasis Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/30/2018 12:49 PM/DISC: 08/30/2018 12:49 PM

http://www.businesswire.com/news/home/20180830005674/en